CAS: 99-33-2; 3,5-Dinitrobenzoyl Chloride

上下游产品

CAS号99-34-3 3,5-二硝基苯甲酸 | CAS号79-37-8 草酰氯 | CAS号65-85-0 苯甲酸 | CAS号40993-10-0 3,5-Dinitrobenz... | CAS号50966-31-9 1,1-dichloro-1-... | CAS号103238-71-7 N-(3,5-Dinitrob... | CAS号10574-44-4 decyl 3,5-dinit... | CAS号10478-02-1 butyl 3,5-dinit... | CAS号10477-99-3 propan-2-yl 3,5... | CAS号99-34-3 3,5-二硝基苯甲酸 | CAS号10478-01-0 Benzoic acid,3,... | CAS号54978-05-1 1-((3,5-dinitro... | CAS号7510-57-8 Benzoic acid, 3... | CAS号40993-10-0 3,5-Dinitrobenz... | CAS号3205-18-3 (S)-(+)-1-苯基乙基3...

3,5-二硝基苯甲酸置于氯化亚砜体系中,化学反应 2.0H,反应生成 3,5-二硝基苯甲酰氯
参考文献:取代苯甲酸亚苄基/呋喃-2-基-亚甲基酰肼作为抗菌剂的hansch分析
标题:取代苯甲酸亚苄基/呋喃-2-基-亚甲基酰肼作为抗菌剂的hansch分析
摘要:合成了一系列取代的酰肼衍生物,并对其进行了体外筛选对五种代表性微生物的抗菌活性.抗菌研究的结果表明,苯甲酸部分上吸电子基团的存在提高了抗菌活性.此外,杂环呋喃的存在不能改善取代的酰肼的抗微生物活性.为了解取代酰肼衍生物的理化参数与抗菌活性之间的关系,通过开发一靶标和多靶标模型进行了qsar研究.与单靶标模型相比,发现多靶标模型可有效描述取代的酰肼的抗菌活性.此外,它还表明了拓扑参数,价三阶分子连接指数(3 χ V)和电子参数,最高能量在描述被取代的酰肼的抗微生物活性占据分子轨道(homo).
DOI:10.1016/j.Ejmech.2008.10.034

专利信息

专利号:US-11548898-B2
优先权日:2017-07-06
标题 :Synthesis of halichondrins
发明人：KISHI YOSHITO; AI YANRAN; YE NING; WANG QIAOYI; YAHATA KENZO; ISO Kentaro; NAINI SANTHOSH REDDY; YAMASHITA SHUJI; LEE JIHOON; OHASHI ISAO; FUKUYAMA TAKASHI
权利人:HARVARD COLLEGE; EISAI R&D MAN CO LTD
摘要:The present invention provides methods for the synthesis of ketones involving a Ni/Zr-mediated coupling reaction. The Ni/Zr-mediated ketolization reactions can be used in the synthesis of halichondrins (e.g., halichondrin A, B, C; homohalichondrin A, B, C; norhalichondrin A, B, C), and analogs thereof. Therefore, the present invention also provides synthetic methods useful for the synthesis of halichondrins, and analogs thereof. Also provided herein are compounds (i.e., intermediates) useful in the synthesis of halichondrins, and analogs thereof. In particular, the present invention provides methods and compounds useful in the synthesis of compound of Formula (H3-A).

专利号:WO-9517903-A1
优先权日:1993-12-28
标 题:Modular design and synthesis of oxazolone-derived molecules
发明人：HOGAN JOSEPH C JR; CASEBIER DAVID; FURTH PAUL; TU CHENG
权利人:ARQULE PARTNERS L P; HOGAN JOSEPH C JR; CASEBIER DAVID; FURTH PAUL; TU CHENG
摘要:The design and synthesis of novel oxazolone-derived molecular modules and the use of the modules in the construction of new molecules and fabricated materials is disclosed. The new molecules and fabricated materials are molecular recognition agents useful in the design and synthesis of drugs, and have applications in separations and materials science.

专利号:US-7619116-B2
优先权日:2003-12-17
标 题:Intermediates for the synthesis of (R)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation
发明人：DAMBRIN VALERY; LENOIR JEAN-YVES; SCHNEIDER JEAN-MARIE; GUILLAMOT GERARD; FOLLET MICHEL; BECKER ABRAM
权利人:PRODUCTS CHIMIQUES AUXILIAIRES
摘要:A subject matter of the present invention is novel intermediates for the synthesis of (R)-tamsulosin and of its pharmaceutically acceptable salts, and also the associated preparation process.

专利号:US-4033949-A
优先权日:1976-04-14
标 题:Analogs of thromboxane B2 and processes for their synthesis
发明人：KELLY ROBERT C; NELSON NORMAN A
权利人:UPJOHN CO
摘要:The present specification provides novel intermediates and novel processes for the synthesis of various side chain and skeletal analogs of Thromboxane B 2 (11β-homo-11a-oxa-PGF 2 .sub.α). These analogs are particularly and especially useful as reproductive cycle control agents.

专利号:US-7994346-B2
优先权日:2001-11-06
标题 :Intermediates for the preparation of lipoxin A4 analogs
发明人：GROSSBACH DANJA; GUILFORD WILLIAM; SANDER MICHAEL
权利人:BAYER SCHERING PHARMA AG
摘要:This invention is directed to compounds useful as intermediates in the synthesis of lipoxin A 4 analogs of the following formulas (I) and (II): n nwherein R 1 , R 2 , R 3 , R 4 and R 5 are described herein. These analogs are useful in treating inflammatory and autoimmune disorders in humans. These analogs are also useful in treating pulmonary or respiratory tract inflammation in humans.

专利号:US-9440991-B2
优先权日:2013-12-23
标 题:Synthesis of an antiviral compound
发明人：CAGULADA AMY; CHAN JOHANN; CHAN LINA; COLBY DENISE A; KARKI KAPIL KUMAR; KATO DARRYL; KEATON KATIE ANN; KONDAPALLY SUDHA; LEVINS CHRIS; LITTKE ADAM; MARTINEZ RUBEN; PCION DOMINIKA; REYNOLDS TROY; ROSS BRUCE; SANGI MICHAEL; SCHRIER ADAM J; SENG PAMELA; SIEGEL DUSTIN; SHAPIRO NATHAN; TANG DONALD; TAYLOR JAMES G; TRIPP JONATHAN; WALTMAN ANDREW W; YU LAWRENCE
权利人:GILEAD SCIENCES INC
摘要:The present disclosure provides processes for the preparation of a compound of formula I: n nwhich is useful as an antiviral agent. The disclosure also provides compounds and processes for the preparation of the compounds that are synthetic intermediates to the compound of formula I.